Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03558087 |
| Title | Gemcitabine, Cisplatin, Plus Nivolumab in Patients With Muscle-invasive Bladder Cancer With Selective Bladder Sparing |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Matthew Galsky |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope | Duarte | California | 91010 | United States | Details | |
| Univerity of Southern California | Los Angeles | California | 90033 | United States | Details | |
| Icahn School of Medicine: Tisch Cancer Institute at Mount Sinai Medical Center | New York | New York | 10029 | United States | Details | |
| Oregon Health & Science University | Portland | Oregon | 97239 | United States | Details | |
| Penn Medicine Abramson Cancer Center | Philadelphia | Pennsylvania | 19104 | United States | Details | |
| Huntsman Cancer Institute University of Utah | Salt Lake City | Utah | 84112 | United States | Details | |
| University of Wisconsin | Madison | Wisconsin | 53705 | United States | Details |